CME Historical Financial Ratios

CME Stock  USD 247.99  0.00  0.00%   
CME is presently reporting on over 113 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Ptb Ratio of 3.8, Capex To Depreciation of 0.24 or Pb Ratio of 3.8 will help investors to properly organize and evaluate CME Group financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About CME Financial Ratios Analysis

CME GroupFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CME investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CME financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CME history.

CME Financial Ratios Chart

At present, CME's PB Ratio is projected to increase slightly based on the last few years of reporting. The current year's ROIC is expected to grow to 0.11, whereas Capex To Depreciation is forecasted to decline to 0.24.
Add Fundamental
Price To Sales RatioPtb Ratio
Capex To DepreciationPb Ratio
RoicInventory Turnover
Net Income Per SharePayables Turnover
Sales General And Administrative To RevenueResearch And Ddevelopement To Revenue
PocfratioInterest Coverage
Capex To Operating Cash FlowPfcf Ratio
Income QualityRoe
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Current RatioReceivables Turnover
Debt To EquityRevenue Per Share
Debt To AssetsDividend Yield
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueEv To Sales
Free Cash Flow Per ShareDays Of Inventory On Hand
Average InventoryCapex To Revenue
Cash Per SharePayout Ratio
Days Payables OutstandingNet Current Asset Value
Tangible Asset ValueNet Debt To E B I T D A
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareCapex Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingDividend Payout Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Enterprise Value Multiple

Price To Sales Ratio

Price to Sales Ratio is figured by comparing CME Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CME sales, a figure that is much harder to manipulate than other CME Group multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.
Most ratios from CME's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At present, CME's PB Ratio is projected to increase slightly based on the last few years of reporting. The current year's ROIC is expected to grow to 0.11, whereas Capex To Depreciation is forecasted to decline to 0.24.
 2022 2023 2024 2025 (projected)
PTB Ratio2.242.833.253.8
Price To Sales Ratio12.0213.5513.618.21

CME fundamentals Correlations

0.0-0.390.00.42-0.410.550.050.430.42-0.590.070.390.550.450.47-0.250.09-0.18-0.39-0.640.10.60.57-0.31-0.06
0.0-0.571.0-0.280.83-0.08-0.670.710.00.550.92-0.85-0.30.68-0.82-0.590.91-0.66-0.730.65-0.57-0.55-0.21-0.51-0.55
-0.39-0.57-0.57-0.34-0.14-0.540.5-0.29-0.420.28-0.350.2-0.37-0.260.160.45-0.330.380.66-0.160.240.05-0.480.550.14
0.01.0-0.57-0.280.83-0.08-0.670.710.00.550.92-0.85-0.30.68-0.82-0.590.91-0.66-0.730.65-0.57-0.55-0.21-0.51-0.55
0.42-0.28-0.34-0.28-0.650.960.21-0.310.42-0.79-0.390.540.97-0.310.590.51-0.40.510.17-0.30.120.250.770.00.07
-0.410.83-0.140.83-0.65-0.52-0.530.58-0.160.90.82-0.99-0.670.55-0.99-0.480.81-0.49-0.520.74-0.4-0.71-0.7-0.34-0.41
0.55-0.08-0.54-0.080.96-0.520.03-0.130.54-0.75-0.220.410.97-0.130.470.33-0.230.37-0.07-0.250.110.260.8-0.16-0.01
0.05-0.670.5-0.670.21-0.530.03-0.230.0-0.3-0.450.510.22-0.220.520.38-0.450.470.43-0.520.480.08-0.030.10.25
0.430.71-0.290.71-0.310.58-0.13-0.230.020.410.89-0.59-0.251.0-0.52-0.670.89-0.63-0.750.07-0.32-0.25-0.32-0.59-0.45
0.420.0-0.420.00.42-0.160.540.00.02-0.37-0.140.090.570.020.130.03-0.150.32-0.38-0.290.270.140.32-0.440.18
-0.590.550.280.55-0.790.9-0.75-0.30.41-0.370.63-0.86-0.820.39-0.89-0.280.62-0.32-0.220.66-0.22-0.67-0.87-0.1-0.32
0.070.92-0.350.92-0.390.82-0.22-0.450.89-0.140.63-0.84-0.40.87-0.79-0.641.0-0.69-0.710.51-0.54-0.55-0.4-0.53-0.56
0.39-0.850.2-0.850.54-0.990.410.51-0.590.09-0.86-0.840.56-0.560.990.43-0.830.430.55-0.750.410.770.660.40.45
0.55-0.3-0.37-0.30.97-0.670.970.22-0.250.57-0.82-0.40.56-0.240.610.44-0.40.510.07-0.410.240.350.77-0.070.13
0.450.68-0.260.68-0.310.55-0.13-0.221.00.020.390.87-0.56-0.24-0.49-0.650.88-0.62-0.720.04-0.31-0.21-0.31-0.56-0.44
0.47-0.820.16-0.820.59-0.990.470.52-0.520.13-0.89-0.790.990.61-0.490.41-0.780.420.49-0.780.40.770.690.340.4
-0.25-0.590.45-0.590.51-0.480.330.38-0.670.03-0.28-0.640.430.44-0.650.41-0.640.870.81-0.040.360.150.180.660.2
0.090.91-0.330.91-0.40.81-0.23-0.450.89-0.150.621.0-0.83-0.40.88-0.78-0.64-0.69-0.70.49-0.54-0.53-0.4-0.51-0.56
-0.18-0.660.38-0.660.51-0.490.370.47-0.630.32-0.32-0.690.430.51-0.620.420.87-0.690.56-0.210.590.090.130.320.21
-0.39-0.730.66-0.730.17-0.52-0.070.43-0.75-0.38-0.22-0.710.550.07-0.720.490.81-0.70.56-0.10.190.290.060.90.36
-0.640.65-0.160.65-0.30.74-0.25-0.520.07-0.290.660.51-0.75-0.410.04-0.78-0.040.49-0.21-0.1-0.43-0.7-0.350.03-0.31
0.1-0.570.24-0.570.12-0.40.110.48-0.320.27-0.22-0.540.410.24-0.310.40.36-0.540.590.19-0.430.280.070.050.32
0.6-0.550.05-0.550.25-0.710.260.08-0.250.14-0.67-0.550.770.35-0.210.770.15-0.530.090.29-0.70.280.550.430.31
0.57-0.21-0.48-0.210.77-0.70.8-0.03-0.320.32-0.87-0.40.660.77-0.310.690.18-0.40.130.06-0.350.070.550.030.06
-0.31-0.510.55-0.510.0-0.34-0.160.1-0.59-0.44-0.1-0.530.4-0.07-0.560.340.66-0.510.320.90.030.050.430.030.27
-0.06-0.550.14-0.550.07-0.41-0.010.25-0.450.18-0.32-0.560.450.13-0.440.40.2-0.560.210.36-0.310.320.310.060.27
Click cells to compare fundamentals

CME Account Relationship Matchups

CME fundamentals Accounts

202020212022202320242025 (projected)
Price To Sales Ratio13.3417.4612.0213.5513.618.21
Ptb Ratio2.472.992.242.833.253.8
Capex To Depreciation0.470.520.430.250.220.24
Pb Ratio2.472.992.242.833.253.8
Roic0.0560.05570.06360.07340.08440.11
Inventory Turnover0.02420.0098690.0052990.0055680.0064030.006083
Net Income Per Share5.887.367.58.999.6910.17
Payables Turnover12.3617.156.29.158.238.92
Sales General And Administrative To Revenue0.03920.03230.02740.02590.02160.0206
Research And Ddevelopement To Revenue0.04060.04110.03760.03920.03530.0282
Pocfratio23.9834.0819.7421.8919.717.9
Interest Coverage15.8715.8518.5421.5519.412.63
Capex To Operating Cash Flow0.07270.05290.02940.02210.02540.0242
Pfcf Ratio25.8735.9820.3422.3925.7528.99
Income Quality1.290.911.141.070.960.77
Roe0.0810.080.09620.10.120.14
Ev To Operating Cash Flow24.6534.3319.9722.1719.9618.03
Pe Ratio30.9431.0522.4223.4423.9713.27
Return On Tangible Assets0.02290.01590.01880.03260.03750.0604
Ev To Free Cash Flow26.5836.2520.5822.6726.0829.06
Earnings Yield0.03230.03220.04460.04270.04170.0342
Intangibles To Total Assets0.260.160.180.240.270.48
Receivables Turnover10.5910.7910.3910.429.377.61
Revenue Per Share13.6513.0913.9915.5417.0617.91
Debt To Assets0.02760.01750.01970.02990.03440.0433
Dividend Yield0.02370.03240.02670.04370.04280.0385
Days Sales Outstanding34.4833.8235.1435.0440.344.1
Book Value Per Share73.6676.4674.9374.4767.0338.69
Free Cash Flow Yield0.03870.02780.04920.04470.05140.0494
Operating Cash Flow Per Share7.596.78.529.628.669.09
Ev To Sales13.7117.5912.1613.7312.358.19
Free Cash Flow Per Share7.046.358.279.418.478.89
Days Of Inventory On Hand15.1K37.0K68.9K65.6K59.0K61.9K
Cash Per Share4.858.237.858.429.6910.09
Payout Ratio0.81.00.830.980.90.56
Days Payables Outstanding29.5321.2858.8439.9145.965.43

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.072
Dividend Share
4.6
Earnings Share
9.66
Revenue Per Share
17.057
Quarterly Revenue Growth
0.062
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.